Curcumin supplementation lowers TNF-α, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-α, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats

Antioxidants and Redox Signaling

Volumn 11, Issue 2, 2009, Pages 241-249

  Jain, Sushil K ^a   Rains, Justin ^a   Croad, Jennifer ^a   Larson, Bryon ^a   Jones, Kimberly ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; OLIVE OIL; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CELL CULTURE; CELL STRAIN U937; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; LIPID PEROXIDATION; MALE; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RAT; SPRAGUE DAWLEY RAT; VASCULITIS;

ANIMALS; BLOOD GLUCOSE; CHEMOKINE CCL2; CURCUMIN; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; GLUCOSE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MONOCYTES; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

RATTUS;

EID: 58149090424     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2140     Document Type: Article

References (62)

1. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, and Price JE. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11: 7490-7498, 2005.
2. Aggarwal BB, Sundram C, Malani N, Ichikawa H. Curcumin: the Indian gold. Adv Exp Med Biol 595: 1-75, 2007.
3. Anand P, Kunnumakkara AB, Newman RA, and Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm 4: 807-818, 2007.
4. Babu P and Srinivasan K. Amelioration of renal lesions associated with diabetes by dietary curcumin in streptozotocin diabetic rats. Mol Cell Biochem 181: 87-96, 1998.
5. Babu P and Srinivasan K. Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem 166: 169-175, 1997.
6. Balasubramanyam M, Koteswari A, Kumar R, Monickaraj S, Maheswari J, and Mohan V. Curcumin-induced inhibition of cellular reactive oxygen species generation: novel therapeutic implications. J Biosci 28: 715-721, 2003.
7. Begum AN, Jones MR, Lim GP, Morihara T, Kim P, Heath DD, Rock CL, Pruitt MA, Yang F, Hudspeth B, Hu S, Faull KF, Teter B, Cole GM, and Frautschy SA. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer disease. J Pharmacol Exp Ther 326: 195-208, 2008.
8. Boring L, Gosling J, Cleary M, and Charo IF. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394: 894-897, 1998.
9. Candiloros H, Muller S, Zeghari N, Donner M, Drouin P, and Ziegler O. Decreased erythrocyte membrane fluidity in poorly controlled IDDM: influence of ketone bodies. Diabetes Care 18: 549-551, 1995.
10. Castelnau PA, Garrett RS, Palinski W, Witztum JL, Campbell IL, and Powell HC. Abnormal iron deposition associated with lipid peroxidation in transgenic mice expressing interleukin-6 in the brain. J Neuropathol Exp Neurol 57: 268-282, 1998.
11. Chen A, Xu J, and Johnson AC. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene 25: 278-287, 2006.
12. Chen A and Xu J. Activation of PPAR- by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR. Am J Physiol Gastrointest Liver Physiol 288: G447-G456, 2005.
13. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, and Hsieh CY. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high risk or premalignant lesions. Anticancer Res 21: 2895-2900, 2001.
14. Cuzzocrea S, De Sarro G, Costantino G, Ciliberto G, Mazzon E, De Sarro A, and Caputi AP. IL-6 knockout mice exhibit resistance to splanchnic artery occlusion shock. J Leukoc Biol 66: 471-480, 1999.
15. Egashira K. Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1. Hypertension 41: 834-841, 2003.
16. Esterbauer H, Lang J, Zadravec S, and Slater T. Detection of malonaldehyde by high-performance liquid chromatography. Methods Enzymol 105: 319-328, 1984.
17. Evans JL, Maddux BA, and Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxidant Redox Signal 7: 1040-1052, 2005.
18. Goel A, Kunnumakkara AB, and Aggarwal BB. Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 75: 787-809, 2008.
19. Guha M, Bai W, Nadler JL, and Natarajan R. Molecular mechanisms of tumor necrosis factor a gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem 275: 17728-17739, 2000.
20. Jain SK, Kannan K, Lim G, McVie R, and Bocchini JA. Hyperketonemia increases TNF-α secretion in cultured U937 monocytes and type-1 diabetic patients. Diabetes 51: 2287-2293, 2002.
21. Jain SK, McVie R, Duett J, and Herbst JJ. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 38: 1539-1543, 1989.
22. Jain SK and McVie R. Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients. Diabetes 48: 1850-1555, 1999.
23. Jain SK, Rains J, and Jones K. Effect of curcumin on protein glycosylation, lipid peroxidation, and oxygen radical generation in human red blood cells exposed to high glucose levels. Free Radic Biol Med 41: 92-96, 2006.
24. Jain SK, Rains JL, and Croad JL. High glucose and ketosis (acetoacetate) increases, and chromium niacinate decreases, IL-6, IL-8, and MCP-1 secretion and oxidative stress in U937 monocytes. Antioxid Redox Signal 9: 1581-1590, 2007.
25. Jain SK. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J Biol Chem 264: 21340-21345, 1989.
26. Jay D, Hitomi H, and Griendling KK: Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med 40: 183-192, 2006.
27. Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N, Ohtsuka-Kowatari N, Kumagai K, Sakamoto K, Kobayashi M, Yamauchi T, Ueki K, Oishi Y, Nishimura S, Manabe I, Hashimoto H, Ohnishi Y, Ogata H, Tokuyama K, Tsunoda M, Ide T, Murakami K, Nagai R, and Kadowaki R. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281: 26602-26614, 2006.
28. Khan N, Afaq F, and Mukhtar H. Cancer chemoprevention through dietary antioxidants: progress and promise. .Antioxid Redox Signal 10: 475-510, 2008.
29. Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, and Aggarwal BB. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res 67: 3853-3861, 2007.
30. Kuwabara N, Tamada S, Iwai T, Teramoto K, Kaneda N, Yokimura T, Nakatani T, and Miura K. Attenuation of renal fibrosis by curcumin in rat obstructive nephropathy. Urology 67: 440-446, 2006.
31. Kowluru RA and Kanwar M. Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab 16: 4-8, 2007.
32. Koyanagi M, Egashira K, Kitamoto S, Ni W, Shimokawa H, Takeya M, Yoshimura T, and Takeshita A. Role of monocyte chemoattractant protein-1 in cardiovascular remodelling induced by chronic blockade of nitric oxide synthesis. Circulation 102: 2243-2248, 2000.
33. Lefer DJ and Granger DN. Monocyte rolling in early atherogenesis: vital role in lesion development. Circ Res 84: 1353-1355, 1999.
34. Mahesh T, Balasubashini M, and Menon V. Effect of photo-irradiated curcumin treatment against oxidative stress in streptozotocin-induced diabetic rats. J Med Food 8: 251-255, 2005.
35. Majithiya JB and Balaraman R. Time-dependent changes in antioxidant enzymes and vascular reactivity of aorta in streptozotocin-induced diabetic rats treated with curcumin. J Cardiovasc Pharmacol 46: 697-705, 2005.
36. McDonnell CM, Pedreira CC, Vadamalayan B, Cameron FJ, and Werther GA. Diabetic ketoacidosis, hyperosmolarity and hypernatremia: Are high carbohydrate drinks worsening initial presentation? Pediatr Diabetes 6: 90-94, 2005.
37. Motterlini R, Foresti R, Bassi R, and Green CJ. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 7: 1303-1312, 2000.
38. Murthy K, Harrington JT, and Siegel RD. Profound hypokalemia in diabetic ketoacidosis: a therapeutic challenge. Endocr Pract 5: 331-334, 2005.
39. Mythri RB, Jagatha B, Pradhan N, Andersen J, and Bharath MM. Mitochondrial complex I inhibition in Parkinson's disease: How can curcumin protect mitochondria? Antioxid Redox Signal 9: 399-408, 2007.
40. Nicolls MR, Haskins K, and Flores SC. Oxidant stress, immune dysregulation, and vascular function in type I diabetes. Antioxid Redox Signal 9: 879-889, 2007.
41. Nishiyama T, Mae T, Kishida H, Tsukagawa M, Mimaki Y, Kuroda M, Sashida Y, Takahashi K, Kawada T, Nakagawa K, and Kitahara M. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L) suppress and increase in blood glucose level in type 2 diabetic KK-Ay mice. J Agric Food Chem 53: 959-963, 2005.
42. Noh H, Ha H, Yu MR, Kim YO, Kim JH, and Lee HB. Angiotension II mediates high glucose-induced TGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species. Periton Dial Int 25: 38-47, 2005.
43. Pari L and Murugan P. Tetrahydrocurcumin prevents brain lipid peroxidation in streptozotocin-induced diabetic rats. J Med Food 10: 323-329, 2007.
44. Pennathur S and Heinecke JW. Mechanisms for oxidative stress in diabetic cardiovascular disease. Antioxid Redox Signal 9: 955-969, 2007.
45. Peroz-Jimenez F, Ruano J, Perez-Martinez P, Lopez-Segura F, and Lopez-Miranda J. The influence of olive oil on human health: not a question of fat alone. Mol Nutr Food Res 51: 1199-1208, 2007.
46. Pugazhenthi S, Akhov L, Selvaraj G, Wang M, and Alam J. Regulation of heme oxygenase-1 expression by demethoxy curcuminoids through Nrf2 by a PI3-kinase/Akt-mediated pathway in mouse β-cells. Am J Physiol Endocrinol Metab 293: E645-E655, 2007.
47. Rollins BJ. Chemokines. Blood 90: 909-928, 1997.
48. Sajithlal G, Chithra P, and Chandrakasan G. Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats. Biochem Pharmacol 56: 1607-1614, 1998.
49. Sandur SK, Pandey MK, Sung B, Ahn KS, Marakami A, Sethi G, Limtrakul P, Badbaev V, and Aggarwal BB. Curcumin demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin, and turmerones differentially regulate anti-inflammatory and antiproliferative responses through a ROS-independent mechanism. Carcinogensis 43: 568-580, 2007.
50. Scapagnini G, Colombrita C, Amadio M, D'Agata V, Arcelli E, Sapienza M, Quattrone A, and Calabrese V. Curcumin activates defensive genes and protects neurons against oxidative stress. Antioxid Redox Signal 8: 395-403, 2006.
51. Shah S, Iqbal M, Karam J, Salifu M, and McFarlane SI. Oxidative stress, glucose metabolism, and the prevention of type 2 diabetes: pathophysiological insights. Antioxid Redox Signal 9: 911-929, 2007.
52. Sharma S, Chopra K, and Kulkarni SK. Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha. Phytother Res 21:278-283, 2007.
53. Sharma S, Kulkarni SK, and Chopra K. Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetes nephropathy in rats. Clin Exp Pharmacol Physiol 33: 940-945, 2006.
54. Sidhu G, Mani H, Gaddipati J, Singh A, Seth P, Banaudha K, Patnaik G, and Maheshwari R. Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Rep Reg 7: 362-374, 1999.
55. Singh U, Devraj S, and Jialal, I. Vitamin E, oxidative stress and inflammation. Annu Rev Nutr 25: 151-174, 2005.
56. Strimpakos AS and Sharma RA. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 10: 511-545, 2008.
57. Suryanarayana P, Saraswat M, Mrudula T, Krishna P, Krishnaswamy K, and Reddy G. Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest Ophthalmol Vis Sci 46: 2092-2099, 2005.
58. Takeya M, Yoshimura T, Leonard EJ, and Takahashi K. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol 24: 534-539, 1993.
59. Wellen KE and Hotamisligil GS. Inflammation, stress, and oxidative stress. J Clin Invest 115: 1111-1119, 2005.
60. Xing L and Remick DG. Promoter elements responsible for antioxidant regulation of MCP-1 gene expression. Antioxid Redox Signal 9: 1979-1989, 2007.
61. Yan LJ, Traber MG, Kobuchi H, Matsugo S, Trischler HJ, and Packer L. Efficacy of hypochlorous acid scavengers in the prevention of protein carbonyl formation. Arch Biochem Biophys 327: 330-334, 1996.
62. Ylä-Herttuala S, Lipton BA, Rosenfeld ME, Särkioja T, Yoshimura T, Leonard EJ, Witztum JL, and Steinberg D. Expression of monocyte chemoattractant protein-1 in macrophage rich areas of human and rabbit atherosclerosis lesions. Proc Natl Acad Sci U S A 88: 5252-5256, 1991.